The Trump administration cracked open the door for the eventual importation of cheaper medicines from abroad, the latest salvo in a battle to bring down drug costs.
Shippers are finally in the position of obtaining real-time, in-transit visibility, but there are some major obstacles standing in the way of full deployment of the appropriate technology.